Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02723175 · ClinicalTrials.gov registry record · NA

The Effects of CBT and tDCS on Fibromyalgia Patients

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT02723175: Completed NA study, sponsored by Medical University of South Carolina.

NCT02723175 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02723175, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

Investigators are seeking to determine the effects of CBT, anodal tDCS over left DLPFC, and combined CBT+ tDCS on clinical pain and functioning among a sample of patients with fibromyalgia. This study will be the first randomized, double-blind, controlled study of tDCS technology as an adjunctive pain management strategy for fibromyalgia pain. Data from this trial will likely yield information regarding the feasibility and efficacy of tDCS+CBT as a chronic pain-management approach.

Primary Outcome

Before treatment, Quantitative Sensory Testing (QST) will be completed for all participants. The QST involves a comprehensive laboratory pain assessment including heat stimuli using a Pathway Thermo-sensory Analyzer System which is specifically designed for assessing laboratory pain testing. The QST collects the temperature in celsius of when the participant first begins to feel the stimuli (Sensory), starts to feel pain (average pain threshold), and when the participant can no longer tolerate t

Interventions

  • DEVICE Transcranial Direct Current Stimulation

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2014-12
Est. Completion 2017-09
Phase NA

What the finished NCT02723175 record still lists

NCT02723175 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Transcranial Direct Current Stimulation is the first listed.

NCT02723175 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02723175 about?

NCT02723175 is a clinical study titled "The Effects of CBT and tDCS on Fibromyalgia Patients". Investigators are seeking to determine the effects of CBT, anodal tDCS over left DLPFC, and combined CBT+ tDCS on clinical pain and functioning among a sample of patients with fibromyalgia. This study will be the first randomized, double-blind, controlled study of tDCS technology as an adjunctive pa...

What is the current status of trial NCT02723175?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2014-12. Estimated completion is 2017-09.

What interventions are being tested in trial NCT02723175?

The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT02723175?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02723175's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02723175, the US trial registry maintained by the National Library of Medicine. NCT02723175 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.